National People's Congress representative and TUS-PHARMA Chairman Jiao Qisen has prepared six proposals this year, covering various aspects such as the overall layout of traditional Chinese medicinal materials, market value management of listed companies, and the low-altitude economy. To avoid the situation where prices of medicinal materials rise leading to blind planting and fall causing harm to farmers, Jiao Qisen believes that a national strategic plan should be formulated. Relevant national departments should take the lead, combining local natural conditions, planting traditions, and industrial foundations to develop a "National Medium and Long-term Plan for the Development of Traditional Chinese Medicinal Materials Industry," clarifying key development areas and directions for planting, processing, and research and development of traditional Chinese medicinal materials in various regions, guiding reasonable resource allocation. Currently, the application scope of ancient classic prescriptions in hospital preparations is limited to the hospital or local area, restricting clinical verification and promotion of these prescriptions. In this regard, Jiao Qisen stated that allowing inter-provincial medical alliances to use these special preparations can enable more patients to access them, breaking regional limitations, promoting the sinking and sharing of medical resources, allowing patients in remote areas to benefit from traditional Chinese medicine therapies, narrowing the gap in medical service levels between regions and medical institutions, and enhancing the overall accessibility and equity of traditional Chinese medical services
